These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20015767)

  • 21. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma.
    Chiang WF; Liu SY; Fang LY; Lin CN; Wu MH; Chen YC; Chen YL; Jin YT
    Oral Oncol; 2008 Apr; 44(4):325-34. PubMed ID: 17588803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: an indicatior of poor prognosis.
    Muñoz-Guerra MF; Marazuela EG; Fernández-Contreras ME; Gamallo C
    Cancer; 2005 Mar; 103(5):960-9. PubMed ID: 15685613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100A2 expression as a predictive marker for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral cavity.
    Suzuki F; Oridate N; Homma A; Nakamaru Y; Nagahashi T; Yagi K; Yamaguchi S; Furuta Y; Fukuda S
    Oncol Rep; 2005 Dec; 14(6):1493-8. PubMed ID: 16273244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of bone morphogenetic proteins (BMPs), their receptors, and activins in normal and scarred conjunctiva: role of BMP-6 and activin-A in conjunctival scarring?
    Andreev K; Zenkel M; Kruse F; Jünemann A; Schlötzer-Schrehardt U
    Exp Eye Res; 2006 Nov; 83(5):1162-70. PubMed ID: 16879818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Tsai TC; Yu CH; Cheng SJ; Liu BY; Chen HM; Chiang CP
    Oral Oncol; 2008 Aug; 44(8):759-66. PubMed ID: 18061525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in bone morphogenetic protein receptor-IB localisation regulate osteogenic responses of human bone cells to bone morphogenetic protein-2.
    Singhatanadgit W; Mordan N; Salih V; Olsen I
    Int J Biochem Cell Biol; 2008; 40(12):2854-64. PubMed ID: 18619554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The suitability of paraffin-embedded material to predict metastatic potential of oral squamous cell carcinoma.
    Van Heerden WF; Dreyer L; Swart TJ; Van Heerden MB; Boy SC
    Anticancer Res; 2002; 22(6C):4147-50. PubMed ID: 12553046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma.
    Sasahira T; Kirita T; Bhawal UK; Yamamoto K; Ohmori H; Fujii K; Kuniyasu H
    Histopathology; 2007 Aug; 51(2):166-72. PubMed ID: 17593216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development.
    Zhang D; Schwarz EM; Rosier RN; Zuscik MJ; Puzas JE; O'Keefe RJ
    J Bone Miner Res; 2003 Sep; 18(9):1593-604. PubMed ID: 12968668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense.
    Silva TA; Ribeiro FL; Oliveira-Neto HH; Watanabe S; Alencar Rde C; Fukada SY; Cunha FQ; Leles CR; Mendonça EF; Batista AC
    Oncol Rep; 2007 Nov; 18(5):1107-13. PubMed ID: 17914560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of metastasis suppressor gene nm23-H1 in oral squamous cell carcinoma and its relation to tumor prognosis].
    Zhang T; Lai Q; Du D
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):292-4. PubMed ID: 11776896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent genetic alterations and reduced expression of the Axin1 gene in oral squamous cell carcinoma: involvement in tumor progression and metastasis.
    Zhou CX; Gao Y
    Oncol Rep; 2007 Jan; 17(1):73-9. PubMed ID: 17143481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
    J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEGF-C is associated with lymphatic status and invasion in oral cancer.
    Siriwardena BS; Kudo Y; Ogawa I; Udagama MN; Tilakaratne WM; Takata T
    J Clin Pathol; 2008 Jan; 61(1):103-8. PubMed ID: 17351086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
    J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma.
    Yoshizawa K; Nozaki S; Okamune A; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
    J Oral Pathol Med; 2009 Jul; 38(6):535-9. PubMed ID: 19473451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of transforming growth factor beta(TGF-beta) subtypes in oral squamous cell carcinoma].
    Jin X; Li J; Li Z; Li Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Dec; 19(6):377-9. PubMed ID: 12539688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues.
    Kim IY; Lee DH; Ahn HJ; Tokunaga H; Song W; Devereaux LM; Jin D; Sampath TK; Morton RA
    Cancer Res; 2000 Jun; 60(11):2840-4. PubMed ID: 10850425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The solution structure of BMPR-IA reveals a local disorder-to-order transition upon BMP-2 binding.
    Klages J; Kotzsch A; Coles M; Sebald W; Nickel J; Müller T; Kessler H
    Biochemistry; 2008 Nov; 47(46):11930-9. PubMed ID: 18937504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.